We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Avg Time Held
6
years
Top 10 Avg Time Held
5.4
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
OSI Systems
OSIS
$3.13B
| $34.2M | 0.03% |
290,350
-3,990
| -1% | -$458K |
2016 Q1
29 quarters
|
|
202
Zoom
ZM
$28.7B
| $34.2M | 0.03% |
503,150
+95,100
| +23% | +$6.36M |
2020 Q1
13 quarters
|
|
203
Lowe's Companies
LOW
$110B
| $33.9M | 0.03% |
150,000
| – | – |
2021 Q1
9 quarters
|
|
204
LPL Financial
LPLA
$25.8B
| $32.6M | 0.03% |
150,000
| – | – |
2020 Q1
13 quarters
|
|
205
Ulta Beauty
ULTA
$26B
| $32.3M | 0.03% |
68,620
-130
| -0.2% | -$63.7K |
2017 Q4
22 quarters
|
|
206
Ollie's Bargain Outlet
OLLI
$5.68B
| $31.7M | 0.03% |
546,790
| – | – |
2021 Q3
7 quarters
|
|
207
Zentalis Pharmaceuticals
ZNTL
$212M
| $31.3M | 0.03% |
1,111,150
-17,770
| -2% | -$426K |
2020 Q2
12 quarters
|
|
208
MongoDB
MDB
$29.5B
| $30.7M | 0.03% |
74,700
-12,800
| -15% | -$3.73M |
2020 Q3
11 quarters
|
|
209
WillScot Mobile Mini Holdings
WSC
$2.97B
| $30.2M | 0.03% |
632,900
+212,800
| +51% | +$9.52M |
2018 Q3
19 quarters
|
|
210
TechnipFMC
FTI
$26.8B
| $30.2M | 0.03% |
1,814,700
| – | – |
2018 Q4
18 quarters
|
|
211
Aurora
AUR
$10.8B
| $30M | 0.03% |
10,218,700
-156,900
| -2% | -$263K |
2021 Q4
6 quarters
|
|
212
CrowdStrike
CRWD
$250B
| $29.8M | 0.02% |
810,340
| – | – |
2019 Q2
16 quarters
|
|
213
Unity
U
$19.1B
| $29.3M | 0.02% |
675,207
-9,600
| -1% | -$307K |
2020 Q3
11 quarters
|
|
214
indie Semiconductor
INDI
$464M
| $28.4M | 0.02% |
3,017,700
-46,000
| -2% | -$415K |
2021 Q3
7 quarters
|
|
215
Bank of New York Mellon
BNY
$96.4B
| $28.4M | 0.02% |
636,800
-9,000
| -1% | -$386K |
2023 Q1
1 quarter
|
|
216
Allogene Therapeutics
ALLO
$463M
| $28M | 0.02% |
5,636,686
-132,300
| -2% | -$716K |
2020 Q4
10 quarters
|
|
217
Kirby Corp
KEX
$7.24B
| $27.2M | 0.02% |
353,100
-14,000
| -4% | -$1.01M |
2020 Q4
10 quarters
|
|
218
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.96B
| $27.1M | 0.02% |
666,377
+9,000
| +1% | +$367K |
2023 Q1
1 quarter
|
|
219
Las Vegas Sands
LVS
$24.8B
| $26.5M | 0.02% |
456,900
-427,300
| -48% | -$25.3M |
2013 Q2
40 quarters
|
|
220
Matsons
MATX
$7.08B
| $25.1M | 0.02% |
322,762
-4,730
| -1% | -$324K |
2019 Q3
15 quarters
|
|
221
Old Dominion Freight Line
ODFL
$39.2B
| $24.5M | 0.02% |
132,700
-76,000
| -36% | -$12.3M |
2017 Q2
24 quarters
|
|
222
Dell
DELL
$301B
| $23.8M | 0.02% |
439,040
-2,620
| -0.6% | -$121K |
2016 Q3
27 quarters
|
|
223
Waters Corp
WAT
$43.6B
| $23.5M | 0.02% |
88,044
+10,200
| +13% | +$2.84M |
2020 Q4
10 quarters
|
|
224
Axon Enterprise
AXON
$33.9B
| $23M | 0.02% |
117,800
-500
| -0.4% | -$104K |
2016 Q2
28 quarters
|
|
225
Cerus
CERS
$455M
| $21.2M | 0.02% |
8,613,000
-203,100
| -2% | -$483K |
2015 Q1
33 quarters
|
|
Similar funds
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.